Format

Send to

Choose Destination
Crit Rev Microbiol. 2011 Nov;37(4):277-312. doi: 10.3109/1040841X.2011.581223. Epub 2011 Jul 13.

Diagnosing invasive fungal disease in critically ill patients.

Author information

1
Division of Pulmonary and Critical Care Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Abstract

Fungal infections are increasing, with a changing landscape of pathogens and emergence of new groups at risk for invasive disease. We review current diagnostic techniques, focusing on studies in critically ill patients. Microbiological cultures, the current "gold standard", demonstrate poor sensitivity, thus diagnosis of invasive disease in the critically ill is difficult. This diagnostic dilemma results in under- or over-treatment of patients, potentially contributing to poor outcomes and antifungal resistance. While other current diagnostic tests perform moderately well, many lack timeliness, efficacy, and are negatively affected by treatments common to critically ill patients. New nucleic acid-based research is promising.

PMID:
21749278
DOI:
10.3109/1040841X.2011.581223
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center